PMID: 3757562Oct 1, 1986Paper

Clinical features of lung cancers discovered as a postmortem "surprise"

Chest
M J McFarlaneC K Wells

Abstract

Despite improved modern diagnostic techniques, many patients with primary lung cancer escape detection of their disease during life. In a review of postmortem records at a university hospital, 28 percent of 153 primary lung cancers found at necropsy had not been diagnosed while the patient was alive. The male/female ratio was 1.3 in this undetected group, compared with 2.3 in the detected group. The main clinical features that seemed to lead to nondiagnosis were a terminal clinical state in patients who were too sick for further diagnostic searches, the absence of suggestive primary symptoms, a chest x-ray film interpreted as not showing primary lung cancer, and the absence of cigarette smoking. Among the patients with lung cancer at necropsy, the proportion of nonsmokers was higher in the previously undiagnosed group than in the group with antemortem diagnoses, even when patients were stratified for primary symptoms. The findings suggest the need for diagnostic alertness to the possibility that curable lung cancer can occur in patients who have a positive chest-film lesion but who are nonsmokers and who lack typical symptoms.

Citations

Aug 1, 1996·Lung Cancer : Journal of the International Association for the Study of Lung Cancer·G Hillerdal
Jun 29, 2001·Lung Cancer : Journal of the International Association for the Study of Lung Cancer·S DammasP C Goodman
Jul 26, 2002·Lung Cancer : Journal of the International Association for the Study of Lung Cancer·Hirsh KoyiLars-Olof Nordesjö
May 18, 2006·Journal of the National Cancer Institute·Michael J ThunEugenia E Calle
Jun 8, 2006·Journal of the National Cancer Institute·Pamela M MarcusRobert S Fontana
Jun 8, 2006·Journal of the National Cancer Institute·Edward F Patz
Dec 7, 2011·Respirology : Official Journal of the Asian Pacific Society of Respirology·Stephen G Spiro, Neal Navani
Feb 13, 2013·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Denise R AberleKathleen Brown
Mar 5, 2008·Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer·Gunnar Hillerdal
Oct 12, 2011·Surgical Oncology Clinics of North America·Brendon M Stiles, Nasser K Altorki
Feb 4, 2010·European Journal of Internal Medicine·Eiran WarnerNimrod Maimon
Dec 17, 2008·The Lancet Oncology·Chee-Keong Toh
Jul 5, 2008·The Lancet Oncology·Peter B Bach
Sep 13, 2015·Clinical Imaging·Kathleen RuchalskiRobert Suh
Jun 5, 2016·Surgical Oncology Clinics of North America·Brendon M StilesNasser K Altorki
Jan 9, 2001·Cancer·R S Fontana
Feb 15, 1991·Cancer·R S FontanaE J Bergstralh
Jan 7, 2010·British Journal of Cancer·A W Castleberry, F W Grannis
Nov 2, 2014·The European Respiratory Journal·Anne K GulsvikAmund Gulsvik
May 25, 2006·The Oncologist·Apar Kishor Ganti, James L Mulshine
Jan 16, 2010·Archives of Pathology & Laboratory Medicine·Lucian R Chirieac, Douglas B Flieder
Mar 1, 1997·Chest·G M StraussD J Sugarbaker

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.